Finding. As mouse tuberculosis becomes chronic, myeloid cells of many kinds turn down mitochondrial electron-transport-chain genes together. Martinez, Watson and colleagues watch that drop travel with weaker antigen presentation, interferon, translation, and glycolysis. Take Complex I down on purpose in macrophages (Ndufs4 knockdown) and MHC-II falls, inflammatory genes lose their script, and Mycobacterium tuberculosis replicates more freely. People who live with patients and convert an interferon-gamma release assay already show almost the same transcriptional program.
Why this paper matters
TB immunology has a metabolism chapter that is usually “infected macrophages go glycolytic.” This study says the chronic myeloid state is a respiratory-chain dimmer switch. The coordination across subsets is the scare: not one exhausted macrophage cluster, a myeloid-wide ETC retreat as disease progresses.
The Ndufs4 experiment is why it is not a word-cloud. Complex I loss is enough to hurt MHC-II and bacterial control. That is a restoration hypothesis with a named subunit, which is rarer than “boost mitochondria.”
The human echo
Household contacts who are IGRA-positive enrich the same remodeling. That does not prove they are about to get sick. It does say the mouse progression signature is not a cage artifact.
How to read the score
High eighties. Organelle-first infection paper, causal Complex I handle, human match. Confidence is high for the mouse knockdown phenomenology, medium for “restore mitochondria in patients.”
Caveats
scRNA-seq ETC modules can be fragile. Knockdown is not a drug. IGRA+ is exposure biology. Do not add a mitochondrial cocktail to a TB regimen from this brief.
What to do with it
If you score immunometabolism or TB, this is a Complex I / MHC-II / myeloid-progression paper. If you look for host-directed therapy ideas, the authors’ own sentence is mitochondrial restoration. Pull the ETC gene trajectory and the Ndufs4 bacterial-load figure.